INO
INO
US45773H4092
Inovio Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 65.343 217.756
70.0%
Cost of Revenue -- --
--
Gross Profit -- --
--
86.887.447 112.616.678
22.8%
Operating Income -86.822.104 -112.398.922
22.8%
Pretax Income -84.945.901 -107.254.126
20.8%
Net Income Common Stockholders -84.945.901 -107.254.126
20.8%
-- --
--
-- --
--
ende